Maxwellia Makes ‘Most Exciting Companies’ List in North West Business Insider Magazine
Alderley Park, UK – 21 May 2021
We at Maxwellia are thrilled to have been chosen as one of North West Business Insider Magazine’s Most Exciting Companies – the fourth annual exclusive list of the top 30 businesses in North West England.
The esteemed selection showcases and commends the ones to watch that are disrupting their sectors and are the most entrepreneurial. It also spotlights those that have the most potential in years to come to succeed and challenge the status quo. This brilliant news comes as we remain poised to launch our first pharmacy brand that will, on regulatory approval, create a major step-change in women’s health and supercharge the power of UK pharmacy.
Based at Alderley Park near Manchester, we are an established pharmaceutical company within the Northern Powerhouse – a government initiative promoting economic growth and talent in the UK‘s great northern cities. Founded in 2013 by Chief Executive Anna Maxwell – a registered pharmacist with over 35 years’ experience, our business specialises solely in ‘switching’, a rigorous process in which prescription only medication is reclassified and made available over the counter. We already have three applications under assessment and a robust pipeline of consumer health care brands under development for over-the-counter sale.
Anna Maxwell says: “We are so proud to be building a new British business in the North West that has innovation at its core. We are honoured to be recognised by North West Business Insider for our efforts and determination in helping make a real difference to the health of the nation by launching vital consumer healthcare products that people can conveniently access from their local pharmacy”.
Read the full entry in the article here »
For interview access, images or any further information, please contact:
Reena Bajwa at The Difference Collective: 07956 181688 / firstname.lastname@example.org
Notes to Editors:
Switching (also termed reclassification) is a rigorous regulatory process facilitating the safe supply of medicines under the supervision of a pharmacist. It is the gold standard for innovation across the global OTC (over the counter) industry where each switch project is unique, intricate and requires precise engineering in order to succeed. Noticing the shortage of exciting OTC innovation, registered pharmacist, founder and CEO Anna Maxwell set up a dedicated operation with a stellar team to build a pipeline of self care innovation that addresses this market challenge.
Founded in 2013, Maxwellia is a female founded, British pharma company and the world’s only company completely dedicated to “switching” – prescription-only medicines into versions that can be bought over the counter in a pharmacy. Switching is a rigorous regulatory process enabling pharmacists to safely supply what were previously prescription-only medicines. Maxwellia is developing and commercialising the next-generation of consumer healthcare pharmacy brands treating a range of conditions in major public health categories. It aims to provide people with new ways to conveniently look after themselves by making widely used and effective medicines available over the counter at the pharmacy.